Literature DB >> 30954494

Complete nucleotide sequence characterization of DRB5 alleles reveals a homogeneous allele group that is distinct from other DRB genes.

Konstantinos Barsakis1, Farbod Babrzadeh2, Anjo Chi2, Kalyan Mallempati3, William Pickle3, Michael Mindrinos2, Marcelo A Fernández-Viña4.   

Abstract

Next Generation Sequencing allows for testing and typing of entire genes of the HLA region. A better and comprehensive sequence assessment can be achieved by the inclusion of full gene sequences of all the common alleles at a given locus. The common alleles of DRB5 are under-characterized with the full exon-intron sequence of two alleles available. In the present study the DRB5 genes from 18 subjects alleles were cloned and sequenced; haplotype analysis showed that 17 of them had a single copy of DRB5 and one consanguineous subject was homozygous at all HLA loci. Methodological approaches including robust and efficient long-range PCR amplification, molecular cloning, nucleotide sequencing and de novo sequence assembly were combined to characterize DRB5 alleles. DRB5 sequences covering from 5'UTR to the end of intron 5 were obtained for DRB5*01:01, 01:02 and 02:02; partial coverage including a segment spanning exon 2 to exon 6 was obtained for DRB5*01:03, 01:08N and 02:03. Phylogenetic analysis of the generated sequences showed that the DRB5 alleles group together and have distinctive differences with other DRB loci. Novel intron variants of DRB5*01:01:01, 01:02 and 02:02 were identified. The newly characterized DRB5 intron variants of each DRB5 allele were found in subjects harboring distinct associations with alleles of DRB1, B and/or ethnicity. The new information provided by this study provides reference sequences for HLA typing methodologies. Extending sequence coverage may lead to identify the disease susceptibility factors of DRB5 containing haplotypes while the unexpected intron variations may shed light on understanding of the evolution of the DRB region.
Copyright © 2019 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  De novo assembly; Gene conversion; HLA-DRB5; Next Generation Sequencing; Single tandem repeats

Mesh:

Substances:

Year:  2019        PMID: 30954494      PMCID: PMC6622178          DOI: 10.1016/j.humimm.2019.04.001

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  64 in total

1.  The insulator protein CTCF represses transcription on binding to the (gt)(22)(ga)(15) microsatellite in intron 2 of the HLA-DRB1(*)0401 gene.

Authors:  R Arnold; W Mäueler; G Bassili; M Lutz; L Burke; T J Epplen; R Renkawitz
Journal:  Gene       Date:  2000-08-08       Impact factor: 3.688

2.  A greedy algorithm for aligning DNA sequences.

Authors:  Z Zhang; S Schwartz; L Wagner; W Miller
Journal:  J Comput Biol       Date:  2000 Feb-Apr       Impact factor: 1.479

3.  HLA-DR51 expression failure caused by a two-base deletion at exon 2 of a DRB5 null allele (DRB5*0110N) in a Spanish gypsy family.

Authors:  A Balas; P Ocon; J L Vicario; A Alonso
Journal:  Tissue Antigens       Date:  2000-05

4.  Major histocompatibility complex proteins and TCRs: do they really go together like a horse and carriage?

Authors:  P Marrack; J Bender; M Jordan; W Rees; J Robertson; B C Schaefer; J Kappler
Journal:  J Immunol       Date:  2001-07-15       Impact factor: 5.422

5.  HLA-DRB5*0101 and -DRB1*1501 expression in the multiple sclerosis-associated HLA-DR15 haplotype.

Authors:  Elisabetta Prat; Utano Tomaru; Lidia Sabater; Deric M Park; Rebekah Granger; Niels Kruse; Joan M Ohayon; Maria P Bettinotti; Roland Martin
Journal:  J Neuroimmunol       Date:  2005-10       Impact factor: 3.478

6.  Redundancy in antigen-presenting function of the HLA-DR and -DQ molecules in the multiple sclerosis-associated HLA-DR2 haplotype.

Authors:  Mireia Sospedra; Paolo A Muraro; Irena Stefanová; Yingdong Zhao; Katherine Chung; Yili Li; Marc Giulianotti; Richard Simon; Roy Mariuzza; Clemencia Pinilla; Roland Martin
Journal:  J Immunol       Date:  2006-02-01       Impact factor: 5.422

7.  Tracing the origin of HLA-DRB1 alleles by microsatellite polymorphism.

Authors:  T F Bergström; H Engkvist; R Erlandsson; A Josefsson; S J Mack; H A Erlich; U Gyllensten
Journal:  Am J Hum Genet       Date:  1999-06       Impact factor: 11.025

8.  Limited diversity of HLA-DRB1*02 alleles and DRB1-DRB5 haplotype associations in four United States population groups.

Authors:  L A Baldassarre; N K Steiner; P Jones; T Tang; R Slack; J Ng; R J Hartzman; C K Hurley
Journal:  Tissue Antigens       Date:  2003-03

9.  Trehalose is a potent PCR enhancer: lowering of DNA melting temperature and thermal stabilization of taq polymerase by the disaccharide trehalose.

Authors:  Andrej-Nikolai Spiess; Nadine Mueller; Richard Ivell
Journal:  Clin Chem       Date:  2004-07       Impact factor: 8.327

10.  Complete MHC haplotype sequencing for common disease gene mapping.

Authors:  C Andrew Stewart; Roger Horton; Richard J N Allcock; Jennifer L Ashurst; Alexey M Atrazhev; Penny Coggill; Ian Dunham; Simon Forbes; Karen Halls; Joanna M M Howson; Sean J Humphray; Sarah Hunt; Andrew J Mungall; Kazutoyo Osoegawa; Sophie Palmer; Anne N Roberts; Jane Rogers; Sarah Sims; Yu Wang; Laurens G Wilming; John F Elliott; Pieter J de Jong; Stephen Sawcer; John A Todd; John Trowsdale; Stephan Beck
Journal:  Genome Res       Date:  2004-05-12       Impact factor: 9.043

View more
  2 in total

1.  Unique Molecular Identifier-Based High-Resolution HLA Typing and Transcript Quantitation Using Long-Read Sequencing.

Authors:  Caleb Cornaby; Maureen C Montgomery; Chang Liu; Eric T Weimer
Journal:  Front Genet       Date:  2022-06-13       Impact factor: 4.772

2.  High Resolution Haplotype Analyses of Classical HLA Genes in Families With Multiple Sclerosis Highlights the Role of HLA-DP Alleles in Disease Susceptibility.

Authors:  Kazutoyo Osoegawa; Lisa E Creary; Gonzalo Montero-Martín; Kalyan C Mallempati; Sridevi Gangavarapu; Stacy J Caillier; Adam Santaniello; Noriko Isobe; Jill A Hollenbach; Stephen L Hauser; Jorge R Oksenberg; Marcelo A Fernández-Viňa
Journal:  Front Immunol       Date:  2021-05-25       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.